Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer?

Wilke, Thomas; Mueller, Sabrina; Bauer, Sabine; Pitura, Silvia; Probst, Leona; Ratsch, Boris A; Salwender, Hans.

Afiliação

Wilke T; Institut für Pharmakoökonomie und Arzneimittellogistik (IPAM), 23966 Wismar, Germany, thomas.wilke@ipam-wismar.de.
Mueller S; Ingress-Health, 23966 Wismar, Germany.
Bauer S; Ingress-Health, 23966 Wismar, Germany.
Pitura S; Takeda Pharma Vertrieb GmbH & Co. KG, 10117 Berlin, Germany.
Probst L; Takeda Pharma Vertrieb GmbH & Co. KG, 10117 Berlin, Germany.
Ratsch BA; Takeda Pharma Vertrieb GmbH & Co. KG, 10117 Berlin, Germany.
Salwender H; Asklepios Kliniken Hamburg GmbH, 22763 Hamburg, Germany.

Patient Prefer Adherence ; 12: 2387-2396, 2018.

Article em En | MEDLINE | ID: mdl-30519004